EGFR and ovarian cancer: AREG is a secreted glycoprotein and low-affinity epidermal growth factor receptor (EGFR) ligand and has an established role in promoting ovarian cell proliferation, metastasis, cancer stemness, and therapy resistance in ovarian cancer (Cheng et al., 2016; Tung et al., 2017).